These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 33516289)

  • 1. Disparities and crisis: access to opioid medicines in Mexico.
    Knaul FM
    Lancet Public Health; 2021 Feb; 6(2):e83-e84. PubMed ID: 33516289
    [No Abstract]   [Full Text] [Related]  

  • 2. Medicines in Mexico, 1990-2004: systematic review of research on access and use.
    Wirtz VJ; Reich MR; Leyva Flores R; Dreser A
    Salud Publica Mex; 2008; 50 Suppl 4():S470-9. PubMed ID: 19082258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Access to medicines by ambulatory health service users in Mexico: an analysis of the national health surveys 1994 to 2006.
    Wirtz VJ; Russo G; Kageyama-Escobar Mde L
    Salud Publica Mex; 2010; 52(1):30-8. PubMed ID: 20464251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication-assisted therapy for opioid-dependent incarcerated populations in New Mexico: statewide efforts to increase access.
    Trigg BG; Dickman SL
    Subst Abus; 2012; 33(1):76-84. PubMed ID: 22263716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Global Opioid Policy Initiative: a wealth of information, but what is next?
    Scholten W
    J Pain Palliat Care Pharmacother; 2014 Mar; 28(1):40-2. PubMed ID: 24467291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is a Reduction in Access to Prescription Opioids the Cure for the Current Opioid Crisis?
    Cicero TJ
    Am J Public Health; 2018 Oct; 108(10):1322-1323. PubMed ID: 30207773
    [No Abstract]   [Full Text] [Related]  

  • 7. The medical consumption of opioids in Colombia, 1997-2007.
    Moyano JR; Figueras A
    J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):367-73. PubMed ID: 21133745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Mexico community voices: policy reform to reduce oral health disparities.
    Powell W; Hollis C; de la Rosa M; Helitzer DL; Derksen D
    J Health Care Poor Underserved; 2006 Feb; 17(1 Suppl):95-110. PubMed ID: 16520517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Access to opioids: a global pain management crisis.
    Buitrago R
    J Pain Palliat Care Pharmacother; 2013 Mar; 27(1):86-7. PubMed ID: 23527674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparities in healthcare services in women with endometriosis with public vs private health insurance.
    Fourquet J; Zavala DE; Missmer S; Bracero N; Romaguera J; Flores I
    Am J Obstet Gynecol; 2019 Dec; 221(6):623.e1-623.e11. PubMed ID: 31226295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid Crisis through the Lens of Social Justice.
    Naegle MA; Finnell DS; Kaplan L; Herr K; Ricciardi R; Reuter-Rice K; Oerther S; Van Hook P
    Nurs Outlook; 2020; 68(5):678-681. PubMed ID: 32980081
    [No Abstract]   [Full Text] [Related]  

  • 12. Improving access to adequate pain management in Taiwan.
    Scholten W
    Acta Anaesthesiol Taiwan; 2015 Jun; 53(2):62-5. PubMed ID: 26068436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Closing the gap: Improving access to trauma care in New Mexico (2007-2017).
    Anderson ES; Greenwood-Ericksen M; Wang NE; Dworkis DA
    Am J Emerg Med; 2019 Nov; 37(11):2028-2034. PubMed ID: 30824273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. India amends Drug Act to simplify access to pain medicines.
    J Pain Palliat Care Pharmacother; 2014 Jun; 28(2):186-7. PubMed ID: 25011140
    [No Abstract]   [Full Text] [Related]  

  • 15. Access to Strong Opioid Analgesics in the Context of Legal and Regulatory Barriers in Eleven Central and Eastern European Countries.
    Vranken MJM; Mantel-Teeuwisse AK; Schutjens MDB; Scholten WK; Jünger S; Leufkens HGM
    J Palliat Med; 2018 Jul; 21(7):963-969. PubMed ID: 29624475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying disparities in access to public-sector abortion based on legislative differences within the Mexico City Metropolitan Area.
    Friedman J; Saavedra-Avendaño B; Schiavon R; Alexander L; Sanhueza P; Rios-Polanco R; Garcia-Martinez L; Darney BG
    Contraception; 2019 Mar; 99(3):160-164. PubMed ID: 30502328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do transdermal opioids affect the personal socioeconomic costs of healthcare access in an australian rural pain population? A comparison with oral opioids.
    Henshaw JS; Walker J; Geraghty D
    J Opioid Manag; 2012; 8(2):126-32. PubMed ID: 22616318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Persisting health and health access inequalities in Mexican indigenous population, 2006-2012].
    Leyva-Flores R; Infante-Xibille C; Gutiérrez JP; Quintino-Pérez F
    Salud Publica Mex; 2013; 55 Suppl 2():S123-8. PubMed ID: 24626687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers to Accessing Internationally Controlled Essential Medicines in Uganda: A Qualitative Study.
    Ooms GI; Klatser P; van den Ham HA; Reed T
    J Pain Symptom Manage; 2019 Nov; 58(5):835-843.e1. PubMed ID: 31302261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers to access to opioid medicines for patients with opioid dependence: a review of legislation and regulations in eleven central and eastern European countries.
    Vranken MJM; Mantel-Teeuwisse AK; Jünger S; Radbruch L; Scholten W; Lisman JA; Subataite M; Schutjens MDB
    Addiction; 2017 Jun; 112(6):1069-1076. PubMed ID: 28087986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.